Carcinoid syndrome differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Carcinoid syndrome must be differentiated from systemic mastocytosis, medullary thyroid carcinoma, irritable bowel syndrome, and malignant neoplasms of the small intestine. | Carcinoid syndrome must be differentiated from [[systemic mastocytosis]], [[medullary thyroid carcinoma]], [[irritable bowel syndrome]], and [[malignant neoplasms]] of the [[small intestine]]. | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Systemic mastocytosis | *Systemic mastocytosis | ||
Revision as of 14:43, 17 September 2015
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome differential diagnosis |
|
Risk calculators and risk factors for Carcinoid syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Carcinoid syndrome must be differentiated from systemic mastocytosis, medullary thyroid carcinoma, irritable bowel syndrome, and malignant neoplasms of the small intestine.
Differential Diagnosis
- Systemic mastocytosis
- Medullary thyroid carcinoma
- Irritable bowel syndrome
- Malignant neoplasms of the small intestine